IEFM
BIIB icon

IQ EQ Fund Management’s Biogen BIIB Stock Holding History

IQ EQ Fund Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-838
Closed -$290K – 262
2021
Q2 		$290K Sell
838
-230
-22% -$69.7K 0.04% 232
2021
Q1 		$299K Hold
1,068
– – 0.05% 218
2020
Q4 		$262K Hold
1,068
– – 0.06% 207
2020
Q3 		$303K Hold
1,068
– – 0.09% 164
2020
Q2 		$286K Hold
1,068
– – 0.1% 161
2020
Q1 		$338K Sell
1,068
-72
-6% -$21.9K 0.14% 108
2019
Q4 		$338K Sell
1,140
-190
-14% -$52.7K 0.11% 119
2019
Q3 		$310K Hold
1,330
– – 0.1% 126
2019
Q2 		$311K Buy
+1,330
New +$307K 0.1% 131
2016
Q1 		– Sell
-3,482
Closed -$1.19M – 90
2015
Q4 		$1.19M Buy
+3,482
New +$1M 0.2% 78

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

IQ EQ Fund Management's BIIB Position: Q3 2021 in Review

IQ EQ Fund Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 838 shares — an estimated $290K sold.

IQ EQ Fund Management first reported a position in BIIB in Q4 2015 and held it in 10 quarters. The position peaked at $1.19M in Q4 2015. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • IQ EQ Fund Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • IQ EQ Fund Management sold 838 Biogen shares in Q3 2021, an estimated $290K.
  • IQ EQ Fund Management first reported a position in Biogen in Q4 2015 and held it in 10 quarters.
  • IQ EQ Fund Management's Biogen position peaked at $1.19M in Q4 2015.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on IQ EQ Fund Management's 13F filing for Q3 2021, filed 27 Oct 2021.